The weekly litigation news digest is live. Subscribe now

Diagnostic Test System For Specific, Sensitive And Reproducible Detection Of Circulating Nucleic Acids In Whole Blood - EP3358020

The patent EP3358020 was granted to Biodesix on May 19, 2021. The application was originally filed on Jan 5, 2018 under application number EP18150429A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3358020

BIODESIX
Application Number
EP18150429A
Filing Date
Jan 5, 2018
Status
Granted And Under Opposition
Apr 16, 2021
Publication Date
May 19, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

QIAGENFeb 21, 2022KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFWITHDRAWN

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS7824889
DESCRIPTIONUSRE43365E
OPPOSITIONEP3358020
OPPOSITIONWO2013045457
OPPOSITIONWO2014049022
OPPOSITIONWO2014146780
OPPOSITIONWO2014146781
OPPOSITIONWO2015140218
OPPOSITIONWO2016020710
SEARCHUS2016186239
SEARCHWO03089899
SEARCHWO2015063121
SEARCHWO2016020710

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents